How HIV-1 Remodels Nuclear Pores to Infect Resting T Cells

The study HIV-1 signalling remodels nuclear pores to licence infection addresses a long-standing paradox in HIV-1 biology. Resting CD4+ T cells are readily found among infected cells in vivo, yet they are highly resistant to cell-free HIV-1 infection in vitro. The work by Mesner and colleagues proposes that permissivity is not determined only by a broad T-cell activation state. Instead, HIV-1 can induce a localized signalling response during cell–cell spread that changes the nuclear pore complex (NPC), enabling viral capsid entry into the nucleus.

Study Background and Research Question

HIV-1 infection requires several coordinated steps: receptor engagement, membrane fusion, cytoplasmic trafficking, reverse transcription, capsid transport to the nuclear envelope, passage through the NPC, and integration of viral DNA into host chromatin. Resting T cells can block infection at one or more of these stages, but the specific rate-limiting barrier has been difficult to define because many experimental systems activate T cells before infection.

Mitogenic activation changes cellular physiology on a large scale. It stimulates signalling pathways, alters the cytoskeleton and nuclear transport machinery, promotes NPC disassembly during mitosis, and drives cell-cycle progression. Consequently, when activated cells become permissive, it is difficult to determine whether HIV-1 requires activation itself or simply benefits from one particular cellular change associated with activation.

The study focuses on cell–cell spread (CCS), in which an infected donor T cell engages an uninfected target T cell through Env–CD4 interactions at a virological synapse. CCS is efficient in lymphoid tissues, where T cells are densely packed and frequently contact one another. The central research question was therefore precise: can HIV-1 make a resting T cell permissive by triggering a receptor-mediated response during cell contact, and if so, which intracellular step is altered?

Key Innovation from the Reference Study

The principal innovation is the separation of viral delivery from contact-induced cellular conditioning. The authors show that the relevant advantage of CCS is not explained solely by a high local multiplicity of infection or a short diffusion distance. Contact with an infected cell actively signals to the target cell and licenses a step that is otherwise inefficient in resting T cells.

Mechanistically, HIV-1 Env engagement of CD4 activates the associated kinase LCK. This signalling axis activates CDK1 even when the target cell does not enter the cell cycle. CDK1 then phosphorylates nucleoporins and remodels the NPC in a way that promotes HIV-1 capsid nuclear import. The resulting model places the NPC at the centre of resting-cell permissivity: the capsid can reach the nuclear envelope, but nuclear entry is normally a bottleneck until CCS-induced signalling changes the pore environment.

This interpretation also explains why cell-free virions behave differently. A free virion can bind and fuse with a target cell, but it does not reproduce the sustained, receptor-organized contact generated by an Env-bearing infected cell. Resting T cells therefore fail to receive the signalling input needed to prime the NPC. The study presents HIV-1 CCS as an active regulatory event rather than merely a more concentrated form of virus exposure.

Methods and Experimental Design Insights

A major strength of the experimental design is its effort to uncouple virological synapse formation from productive virus transfer. The authors used a full-length HIV-1 NL4.3 construct carrying an Env fusion-peptide mutation, Env-F522Y, to create an experimental context in which Env-dependent contact could be examined independently of normal membrane fusion. This strategy helps distinguish the effect of cell contact from the downstream consequences of delivering a large number of virions into the target cell.

The study combines viral assays, cellular signalling measurements, infection readouts, and super-resolution imaging. The comparison of resting and mitogen-activated primary T cells provides a physiological framework, while the comparison of cell-free virus and CCS tests whether the route of exposure changes the permissive state. Imaging is particularly important because the proposed mechanism concerns the spatial relationship between HIV-1 capsid, the nuclear envelope, and individual NPCs rather than only total infection frequency.

The investigators also follow the pathway from receptor engagement to nuclear transport. CD4–LCK signalling, CDK1 activation, nucleoporin phosphorylation, and capsid nuclear import are treated as connected mechanistic steps. This sequence is stronger than an endpoint-only experiment because it links an extracellular contact event to a defined nuclear transport phenotype.

Protocol Parameters

• Cell-state comparison: Analyze resting primary CD4+ T cells alongside activated cells so that increased infection is not interpreted as a generic consequence of cell viability or proliferation.
• Exposure-route comparison: Include cell-free virus and donor–target cell contact conditions to distinguish virion dose effects from contact-induced signalling.
• Contact uncoupling: Use an Env fusion-defective system such as the study’s Env-F522Y design when the experimental goal is to isolate receptor-mediated contact from productive membrane fusion.
• Mechanistic readouts: Measure signalling through CD4–LCK and CDK1 together with nucleoporin phosphorylation and capsid nuclear localization; these are complementary endpoints rather than interchangeable measures of infection.
• Spatial validation: Use high-resolution imaging to test whether capsid accumulation and nuclear entry occur at remodeled NPC regions, while treating imaging-based localization as evidence that should be integrated with functional infection assays.

These parameters describe the logic of the reference study and provide a framework for replication. Exact cell numbers, virus inputs, timing, imaging settings, and perturbation conditions should be taken from the full article and adapted to the primary-cell system being used.

Core Findings and Why They Matter

Cell contact restores permissivity in resting T cells

The study shows that contact with an infected T cell can make a resting target cell permissive to HIV-1. This finding challenges the simple view that resting T cells are intrinsically non-permissive until they undergo mitogenic activation. A resting cell may instead be conditionally permissive when it receives the right short-range signal from an infected neighbor.

Nuclear import is a critical bottleneck

The data place capsid nuclear import, rather than virus binding or membrane fusion alone, at a rate-limiting stage in resting-cell infection. This distinction matters experimentally. A failure to detect productive infection does not necessarily mean that virus has failed to enter the cell; the relevant restriction may occur later, at the transition from cytoplasmic trafficking to nuclear access.

CD4–LCK–CDK1 signalling remodels the NPC

Env–CD4 engagement initiates a signalling cascade involving LCK and CDK1. The study links CDK1 activity to nucleoporin phosphorylation and NPC priming. Importantly, this response does not require the target T cell to enter the cell cycle, separating the infection-promoting event from the broad cellular changes caused by mitogenic stimulation.

The mechanism helps explain why CCS dominates infection

CCS has often been attributed to the delivery of more virus at the contact site. The reference study adds a second explanation: cell contact accelerates the intracellular step that limits infection. The effect is also observed in activated T cells, where contact further increases nuclear import. Thus, CCS may be efficient in both resting and activated cells because it combines directed viral delivery with active preparation of the nuclear transport interface.

Implications for infection in vivo

The findings provide a mechanistic explanation for how resting CD4+ T cells can contain integrated provirus in vivo. They support the possibility that some resting cells are infected directly through CCS rather than exclusively through infection of previously activated cells that later return to quiescence. The result does not eliminate other routes of infection, but it identifies a plausible tissue-level mechanism operating under conditions of frequent T-cell contact.

Comparison with Existing Internal Articles

The internal article Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry examines a different viral system and reports that genotype III grass carp reovirus depends on clathrin-mediated, dynamin-dependent entry pathways. Its inhibitor-based analysis is useful as a conceptual comparison because both studies investigate how viruses exploit host-cell machinery, but they address different stages: the grass carp reovirus work focuses on uptake and entry, whereas the HIV-1 study identifies a post-entry nuclear transport barrier and an NPC-remodeling response.

Why this cross-domain matters, maturity, and limitations

The comparison illustrates why “viral entry” should not be treated as a single event. In one system, endocytic machinery and acidification are central; in the other, receptor signalling and nuclear pore regulation determine whether infection proceeds after cytoplasmic delivery. These findings can inform assay design across virology, but they do not establish that clathrin, dynamin, or pH-dependent trafficking controls the HIV-1 CD4–LCK–CDK1 mechanism. The bridge is therefore methodological rather than evidence for a shared molecular pathway.

Limitations and Transferability

The work uses primary human T cells and carefully controlled contact models, but ex vivo systems cannot reproduce every feature of lymphoid tissue. Cell density, antigen-presenting cells, cytokine gradients, extracellular matrix, and the diversity of donor and target cells may influence signalling and NPC organization in vivo. The proposed mechanism is highly relevant to tissue infection, yet its quantitative contribution to total infection in people remains to be established.

The Env-F522Y system is a powerful separation tool, but any fusion-defective construct may alter Env behavior in ways that are not identical to wild-type CCS. Conclusions should therefore be supported by complementary experiments using productive cell–cell spread. Similarly, super-resolution localization can show spatial relationships at the nuclear envelope but should be interpreted alongside functional measurements of nuclear import and integrated infection.

Transferability to other viruses, immune-cell types, or non-lymphoid cells is also uncertain. The study demonstrates a specific HIV-1 strategy involving CD4, LCK, CDK1, and nucleoporins. It should not be generalized to all nuclear-import processes without direct testing. Finally, the study does not imply that every kinase inhibitor affecting T-cell signalling will reproduce the phenotype; pathway selectivity, timing, and effects on cell viability would need independent validation.

Research Support Resources

For separate Pak1-focused signalling workflows, researchers can use IPA-3 (SKU B2169), also known as 1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol. Product information describes it as a non-ATP competitive Pak1 inhibitor with a reported 2.5 μM IC50, suitable for Pak1 autophosphorylation inhibition and a kinase activity assay. Such work may be relevant to cancer biology research or spinal cord injury recovery research, but IPA-3 is not a reagent validated by this HIV-1 paper and should not be used to infer that Pak1 controls the CD4–LCK–CDK1–NPC pathway.